RETRACTED: Effect of folate and mecobalamin on hip fractures in patients with stroke - A randomized controlled trial (Retracted article. See vol. 315, pg. 2405, 2016)

被引:210
作者
Sato, Y
Honda, Y
Iwamoto, J
Kanoko, T
Satoh, K
机构
[1] Mitate Hosp, Dept Neurol, Tagawa 8260041, Japan
[2] Keio Univ, Sch Med, Dept Sports Med, Tokyo, Japan
[3] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Rehabil Med, Hirosaki, Aomori 036, Japan
[4] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 036, Japan
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 09期
关键词
D O I
10.1001/jama.293.9.1082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Stroke increases the risk of subsequent hip fracture by 2 to 4 times. Hyperhomocysteinemia is a risk factor for both ischemic stroke and osteoporotic fractures in elderly men and women. Treatment with folate and mecobalamin (vitamin B-12) may improve hyperhomocysteinemia. Objective To investigate whether treatment with folate and vitamin B12 reduces the incidence of hip fractures in patients with hemiplegia following stroke. Design, Setting, and Patients A double-blind, randomized controlled study of 628 consecutive patients aged 65 years or older with residual hemiplegia at least 1 year following first ischemic stroke, who were recruited from a single Japanese hospital from April 1, 2000, to May 31, 2001. Patients were assigned to daily oral treatment with 5 mg of folate and 1500 mug of mecobalamin, or double placebo; 559 completed the 2-year follow-up. Main Outcome Measure Incidence of hip fractures in the 2 patient groups during the 2-year follow-up. Results At baseline, patients in both groups had high levels of plasma homocysteine and low levels of serum cobalamin and serum folate. After 2 years, plasma homocysteine levels decreased by 38% in the treatment group and increased by 31 % in the placebo group (P<.001). The number of hip fractures per 1000 patient-years was 10 and 43 for the treatment and placebo groups, respectively (P<.001). The adjusted relative risk, absolute risk reduction, and the number needed to treat for hip fractures in the treatment vs placebo groups were 0.20 (95% confidence interval [CI], 0.080.50), 7.1 % (95% Cl, 3.6%-10.8%), and 14 (95% Cl, 9-28), respectively. No significant adverse effects were reported. Conclusion In this Japanese population with a high baseline fracture risk, combined treatment with folate and vitamin 131, is safe and effective in reducing the risk of a hip fracture in elderly patients following stroke.
引用
收藏
页码:1082 / 1088
页数:7
相关论文
共 41 条
[1]   PLASMA SULFHYDRYL-CONTAINING AMINO-ACIDS IN PATIENTS WITH CEREBRAL INFARCTION AND IN HYPERTENSIVE SUBJECTS [J].
ARAKI, A ;
SAKO, Y ;
FUKUSHIMA, Y ;
MATSUMOTO, M ;
ASADA, T ;
KITA, T .
ATHEROSCLEROSIS, 1989, 79 (2-3) :139-146
[2]  
ASPLUND K, 1985, STROKE, V16, P885
[3]   Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women [J].
Bainbridge, KE ;
Sowers, M ;
Lin, XH ;
Harlow, SD .
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (06) :439-446
[4]   Homocysteine and short-term risk of myocardial infarction and stroke in the elderly -: The Rotterdam study [J].
Bots, ML ;
Launer, LJ ;
Lindemans, J ;
Hoes, AW ;
Hofman, A ;
Witteman, JCM ;
Koudstaal, PJ ;
Grobbee, DE .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) :38-44
[5]   IMPAIRED HOMOCYSTEINE METABOLISM IN EARLY-ONSET CEREBRAL AND PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE - EFFECTS OF PYRIDOXINE AND FOLIC-ACID TREATMENT [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
NORRVING, B ;
BERGQVIST, D ;
THORNE, J ;
HULTBERG, B ;
HAMFELT, A .
ATHEROSCLEROSIS, 1990, 81 (01) :51-60
[6]   HYPERHOMOCYSTEINAEMIA IN STROKE - PREVALENCE, CAUSE, AND RELATIONSHIPS TO TYPE OF STROKE AND STROKE RISK-FACTORS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
MALINOW, MR ;
NORRVING, B ;
UPSON, B ;
HAMFELT, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (03) :214-221
[7]   HOMOCYST(E)INAEMIA AND BONE-DENSITY IN ELDERLY WOMEN [J].
BROWNER, WS ;
MALINOW, MR .
LANCET, 1991, 338 (8780) :1470-1470
[8]   A PROSPECTIVE-STUDY ON HIP-FRACTURES IN PATIENTS WITH PREVIOUS CEREBROVASCULAR ACCIDENTS [J].
CHIU, KY ;
PUN, WK ;
LUK, KDK ;
CHOW, SP .
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 1992, 23 (05) :297-299
[9]   Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].
Cummings, SR ;
Black, DM ;
Thompson, DE ;
Applegate, WB ;
Barrett-Connor, E ;
Musliner, TA ;
Palermo, L ;
Prineas, R ;
Rubin, SM ;
Scott, JC ;
Vogt, T ;
Wallace, R ;
Yates, AJ ;
LaCroix, AZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082
[10]   Effect of calcium and vitamin D supplementation on bone, density in men and women 65 years of age or older [J].
DawsonHughes, B ;
Harris, SS ;
Krall, EA ;
Dallal, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) :670-676